Eades William, Abdolmohammadpourbonab Shayan, Dinh Linh, Yan Bingfang
Division of Pharmaceutical Sciences, University of Cincinnati, Cincinnati, OH, USA.
Pharm Dev Technol. 2024 Dec;29(10):1065-1074. doi: 10.1080/10837450.2024.2417004. Epub 2024 Oct 18.
Ionic liquids (ILs) are considered salt in liquid state, which is composed of organic cations and anions with low melting points (<100 °C). ILs have become a major scientific area with an extensive range of applications including chemistry, electrochemistry, and pharmaceutics. ILs have received great research interest in the pharmaceutical field as solvents, anti-solvents, co-solvents, and reagents in synthesis and formulation. While therapeutic ILs have been investigated for oral and trans-dermal drug delivery systems showing promising compatibility with a wide range of therapeutics, enhanced drug permeation through the skin, and cell membrane solvation to open channels to facilitate molecular passage, their potential to cross the challenging blood-brain barrier (BBB) remains an unanswered question. IL-based therapies could potentially be a game changer for improving drug delivery to cellular targets both at and across the BBB. In this review, we discuss (1) the tunable physicochemical properties of ILs; (2) the vast and various applications of ILs in the development and improvement of drug delivery systems; and (3) ILs as a potential approach for increasing drug accumulation in the brain tissue.
离子液体(ILs)被认为是处于液态的盐,它由有机阳离子和熔点较低(<100°C)的阴离子组成。离子液体已成为一个重要的科学领域,具有广泛的应用,包括化学、电化学和制药学。在制药领域,离子液体作为合成和制剂中的溶剂、反溶剂、共溶剂和试剂受到了极大的研究关注。虽然已经对治疗性离子液体用于口服和透皮给药系统进行了研究,显示出与多种治疗药物具有良好的相容性、增强药物透过皮肤的能力以及使细胞膜溶剂化以打开通道促进分子通过,但它们穿越具有挑战性的血脑屏障(BBB)的潜力仍然是一个未解决的问题。基于离子液体的疗法可能会成为改善药物向血脑屏障处及穿过血脑屏障的细胞靶点递送的游戏规则改变者。在这篇综述中,我们讨论了:(1)离子液体可调节的物理化学性质;(2)离子液体在药物递送系统的开发和改进中的广泛多样的应用;以及(3)离子液体作为增加脑组织中药物蓄积的一种潜在方法。
Int J Mol Sci. 2020-11-5
Drug Discov Today. 2020-5
Int J Pharm. 2022-1-25
Adv Sci (Weinh). 2024-11
Adv Sci (Weinh). 2024-6
Adv Drug Deliv Rev. 2023-6
Pharmaceutics. 2023-4-7